Scientists identified the methyltransferase-like 3/microRNA-221-3p/homeodomain-interacting protein kinase 2/Che-1 (METTL3/miR-221-3p/HIPK2/Che-1) axis as a novel signaling event that may be responsible for resistance of breast cancer cells to adriamycin.
[Experimental and Molecular Medicine]
6807162 {6807162:HQN3LZYX} apa 50 1 157726 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-8b7529263a339232bb62d7bd178970d7%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HQN3LZYX%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pan%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPan%2C%20X.%2C%20Hong%2C%20X.%2C%20Li%2C%20S.%2C%20Meng%2C%20P.%2C%20%26amp%3B%20Xiao%2C%20F.%20%282021%29.%20METTL3%20promotes%20adriamycin%20resistance%20in%20MCF-7%20breast%20cancer%20cells%20by%20accelerating%20pri-microRNA-221-3p%20maturation%20in%20a%20m6A-dependent%20manner.%20%3Ci%3EExperimental%20%26amp%3B%20Molecular%20Medicine%3C%5C%2Fi%3E%2C%201%26%23x2013%3B12.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs12276-020-00510-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs12276-020-00510-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DHQN3LZYX%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22METTL3%20promotes%20adriamycin%20resistance%20in%20MCF-7%20breast%20cancer%20cells%20by%20accelerating%20pri-microRNA-221-3p%20maturation%20in%20a%20m6A-dependent%20manner%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaoping%22%2C%22lastName%22%3A%22Pan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaolv%22%2C%22lastName%22%3A%22Hong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumei%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ping%22%2C%22lastName%22%3A%22Meng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Xiao%22%7D%5D%2C%22abstractNote%22%3A%22Breast%20cancer%20%28BC%29%20is%20the%20most%20prevalent%20malignant%20neoplasm%20among%20women%20and%20is%20the%20fifth%20most%20common%20cause%20of%20cancer-associated%20death%20worldwide.%20Acquired%20chemoresistance%20driven%20by%20genetic%20and%20epigenetic%20alterations%20is%20a%20significant%20clinical%20challenge%20in%20treating%20BC.%20However%2C%20the%20mechanism%20of%20BC%20cell%20resistance%20to%20adriamycin%20%28ADR%29%20remains%20to%20be%20elucidated.%20In%20this%20study%2C%20we%20identified%20the%20methyltransferase-like%203%5C%2FmicroRNA-221-3p%5C%2Fhomeodomain-interacting%20protein%20kinase%202%5C%2FChe-1%20%28METTL3%5C%2FmiR-221-3p%5C%2FHIPK2%5C%2FChe-1%29%20axis%20as%20a%20novel%20signaling%20event%20that%20may%20be%20responsible%20for%20resistance%20of%20BC%20cells%20to%20ADR.%20A%20dual-luciferase%20reporter%20gene%20assay%20was%20employed%20to%20test%20the%20presence%20of%20miR-221-3p%20binding%20sites%20in%20the%203%5Cu2032UTR%20of%20HIPK2.%20Drug%20resistance%20was%20evaluated%20by%20immunoblotting%20multidrug%20resistance%20protein%201%20%28MDR1%29%20and%20breast%20cancer%20resistance%20protein%20%28BCRP%29.%20Cultured%20ADR-resistant%20MCF-7%20cells%20were%20assayed%20for%20their%20half%20maximal%20inhibitory%20concentration%20%28IC50%29%20values%20and%20apoptosis%20using%20an%20MTT%20assay%20and%20Annexin%20V-FITC%5C%2FPI-labeled%20flow%20cytometry%2C%20and%20the%20cells%20were%20then%20xenografted%20into%20nude%20mice.%20METTL3%20knockdown%20was%20shown%20to%20reduce%20the%20expression%20of%20miR-221-3p%20by%20reducing%20pri-miR-221-3p%20m6A%20mRNA%20methylation%2C%20thereby%20reducing%20the%20IC50%20value%20of%20ADR-resistant%20MCF-7%20cells%2C%20reducing%20the%20expression%20of%20MDR1%20and%20BCRP%2C%20and%20inducing%20apoptosis.%20Mechanistically%2C%20miR-221-3p%20was%20demonstrated%20to%20negatively%20regulate%20HIPK2%20and%20upregulate%20its%20direct%20target%20Che-1%2C%20thus%20leading%20to%20enhanced%20drug%20resistance%20in%20ADR-resistant%20MCF-7%20cells.%20In%20vitro%20results%20were%20reproduced%20in%20nude%20mice%20xenografted%20with%20ADR-resistant%20MCF-7%20cells.%20Our%20work%20elucidates%20an%20epigenetic%20mechanism%20of%20acquired%20chemoresistance%20in%20BC%2C%20in%20support%20of%20the%20METTL3%5C%2FmiR-221-3p%5C%2FHIPK2%5C%2FChe-1%20axis%20as%20a%20therapeutic%20target%20for%20the%20improvement%20of%20chemotherapy.%22%2C%22date%22%3A%222021-01-08%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs12276-020-00510-w%22%2C%22ISSN%22%3A%222092-6413%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs12276-020-00510-w%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-08T21%3A08%3A17Z%22%7D%7D%5D%7D
Pan, X., Hong, X., Li, S., Meng, P., & Xiao, F. (2021). METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner. Experimental & Molecular Medicine, 1–12. https://doi.org/10.1038/s12276-020-00510-w Cite